• facebook
  • ihuza
  • Youtube

Kugaragara kwa SARS-CoV-2 B.1.1.7 Imirongo-

Amerika, ku ya 29 Ukuboza 2020-Ku ya 12 Mutarama 2021

Impeshyi E. Galloway, PhD 1;Prabasaj Paul, PhD 1;Duncan R. MacCannell, PhD 2;Michael A. Johansson, PhD 1;

John T. Brooks, MD 1;Adam MacNeil, PhD 1;Rachel B. Slayton, PhD 1;Suxiang Tong, PhD 1;Benjamin J. Silk, PhD 1;Gregory L. Armstrong, MD 2;

Matayo Biggerstaff, ScD 1;Vivien G. Dugan, PhD

Ku ya 15 Mutarama 2021, iyi raporo yashyizwe kuri MMWRKurekurwa hakiri kare kurubuga rwa MMWR (https://www.cdc.gov/mmwr).

Ku ya 14 Ukuboza 2020, Ubwongereza bwatangajea SARS-CoV-2 impinduka (VOC), umurongo B.1.1.7,nanone yitwa VOC 202012/01 cyangwa 20I / 501Y.V1. * TheBivugwa ko B.1.1.7 impinduka zagaragaye muri Nzeri2020 kandi byahise bihinduka byiganjemo kuzengurukaImpinduka ya SARS-CoV-2 mu Bwongereza (1).B.1.1.7 yabayebyagaragaye mu bihugu birenga 30, harimo na Amerika.Nkyo ku ya 13 Mutarama 2021, abagera kuri 76 ba B.1.1.7 bafitebyagaragaye muri leta 12 zo muri Amerika.Imirongo myinshi yibimenyetsoerekana ko B.1.1.7 yanduye neza kurutaizindi SARS-CoV-2 zitandukanye (1-3).Icyitegererezo cyerekanaiyi variant muri Amerika yerekana iterambere ryihuse muntangiriro ya 2021,guhinduka ibintu byiganje muri Werurwe.YiyongereyeKwanduza SARS-CoV-2 bishobora guhungabanya ubuvuzi bukomeyeibikoresho, bisaba kwaguka no kurushaho gushyira mubikorway'ingamba z'ubuzima rusange (4), no kongera ijanisha ryaubudahangarwa bw'abaturage busabwa mu kurwanya icyorezo.Gufataingamba zo kugabanya kwanduza ubu zirashobora kugabanya ubushoboziingaruka za B.1.1.7 no kwemerera igihe gikomeye cyo kongera urukingogukwirakwiza.Hamwe na hamwe, byongerewe imbaraga zo kugenzura genomicbyahujwe no gukomeza kubahiriza abaturage nezaingamba z'ubuzima, zirimo gukingirwa, intera y'umubiri,gukoresha masike, isuku yintoki, no kwigunga na karantine, ubushakekuba ngombwa mu kugabanya ikwirakwizwa rya SARS-CoV-2, virusiitera indwara ya coronavirus 2019 (COVID-19).Ingambakwipimisha abantu badafite ibimenyetso ariko bafite ibyago byinshi byokwandura, nk'abanduye SARS-CoV-2 cyangwa abafiteinshuro nyinshi idashobora kwirindwa nabantu, itanga indiamahirwe yo kugabanya ikwirakwizwa.

Igenzura rya genomic kwisi yose kandi byihuse bifungura-isoko sharingirangingo za virusi zikurikirana byoroheje hafi yigihe-nyacyogutahura, kugereranya, no gukurikirana iterambere rya SARS-CoV-2impinduka zishobora kumenyesha imbaraga zubuzima rusange kugenzura iicyorezo.Mugihe ihinduka ryimiterere muri genome ya virusikwigaragaza hanyuma ugasubira inyuma, abandi barashobora gutanga inama yatoranijwetage kuri variant, harimo nogukwirakwiza kwinshi, kugirangoibintu nkibi birashobora kuganza byihuse izindi zizenguruka.

Kera mubyorezo, variant za SARS-CoV-2 zirimoihinduka rya D614G muri proteine ​​ya spike (S) yiyongerareseptor binding avidity byihuse byiganje muri benshiuturere (5,6).Mu mpera z'umwaka wa 2020, ibihugu byinshi byatangaje ko byabonyeImpinduka za SARS-CoV-2 zikwirakwira neza.Byongeyekuri variant ya B.1.1.7, impinduka zigaragara zirimo B.1.351ibisekuru byagaragaye bwa mbere muri Afrika yepfo kandi biherutse kumenyekanaB.1.1.28 subclade (yahinduwe izinaP.1) byagaragaye mu bagenzi banekuva muri Berezile mugihe cyo kwisuzumisha bisanzwe kuri Haneda (Tokiyo)ikibuga cyindege.§ Izi variants zitwara inyenyeri ya muta genetiquetions, harimo muri S protein reseptor-ihuza indangarubuga,ni ngombwa mu guhuza ingirabuzimafatizo angiotensin-guhindura enzyme-2 (ACE-2) reseptor kugirango yorohereze virusikwinjira.Ibimenyetso byerekana ko izindi mutation ziboneka muribiimpinduka zishobora gutanga gusa uburyo bwo kwanduza gusa arikoBirashobora kandi kugira ingaruka kumikorere ya bimwe byo gusuzuma-igiheInyandikomvugo-urunigi rwa polymerase (RT-PCR)askandi ugabanye kwanduza antibodies(2,3,5-10).Raporo yimanza iherutse kwerekana urubanza rwa mbere rwaKugarura SARS-CoV-2 muri Berezile hamwe na SARS-CoV-2yarimo mutation ya E484K, ** yerekanwekugabanya kutabogama na convalescent sera na monoclonalantibodies (9,10).

Iyi raporo yibanze ku kugaragara kwa variant ya B.1.1.7muri Amerika.Kuva ku ya 12 Mutarama 2021, nta naB.1.351 cyangwa impinduka za P.1 zagaragaye muriLeta zunz'ubumwe.Kumakuru yerekeye SARS-CoV-2 igaragaraimpinduka zimpungenge, CDC ikomeza urubuga rwahariwegutanga amakuru kubyerekeranye na SARS-CoV-2 igaragara.††

 B.1.1.7 ibisekuru (20I / 501Y.V1)

Impinduka ya B.1.1.7 itwara ihinduka muri poroteyine S.(N501Y) bigira ingaruka kumihindagurikire ya reseptor-bindingindangarubuga.Iyi variant ifite izindi 13 B.1.1.7 imirongo-isobanura imirongo (Imbonerahamwe), inyinshi murizo ziri muri poroteyine S,harimo gusiba kumwanya wa 69 na 70 (del69-70) ibyoyahindutse ubwayo mubindi SARS-CoV-2 ihinduka kandi nihypothesize kugirango yongere kwanduzwa (2,7).Gusibaku myanya 69 na 70 itera S-gene intego yo kunanirwa (SGTF)byibuze RT-PCR imwe-ishingiye ku gusuzuma (urugero, hamwe naThermoFisher Taq Inzira COVID-19 isuzuma, B.1.1.7ibimonyo nibindi bitandukanye hamwe na del69-70 bitanga umusaruro mubiibisubizo kuri S-gene intego nigisubizo cyiza kubindi bibiriintego);SGTF yabaye intumwa mu Bwongerezayo kumenya imanza B.1.1.7 (1).Imirongo myinshi yibimenyetso yerekana ko B.1.1.7 ari byinshikwanduzwa neza ugereranije nizindi SARS-CoV-2variants zizenguruka mu Bwongereza.Uturere two mu Bwongereza hamweumubare munini wa B.1.1.7 zikurikiranye zagize icyorezo cyihusegukura kuruta utundi turere, kwisuzumisha hamwe na SGTF byariyongereyebyihuse kuruta kwisuzumisha bitari SGTF mubice bimwe, na aumubare munini wimibonano yanduye abarwayi berekanahamwe na B.1.1.7 kwandura kuruta kubarwayi banduye banduyeubundi buryo (1,3).Impinduka B.1.1.7 ifite ubushobozi bwo kongera pan muri Amerikainzira ya demic mumezi ari imbere.Kugaragaza iyi ngaruka,icyitegererezo cyoroshye, bibiri-bitandukanye bigizwe nicyitegererezo.Kugeza ubu Amerika yamamaye B.1.1.7 mubantu bose bazengurukavirusi ntizwi ariko ikekwa kuba <0.5% ishingiye kuriumubare muto wimanza zagaragaye hamwe namakuru ya SGTF (8).Kuriicyitegererezo, ibitekerezo byambere birimo B.1.1.7ya 0.5% mu ndwara zose, ubudahangarwa bwa SARS-CoV-2 kuvakwandura mbere kwa 10%-30%, imyororokere itandukanyeumubare (R t) ya 1.1 (kugabanya ariko kwiyongera)cyangwa 0.9 (kugabanya kwanduza) kubitandukanye byubu, kandi byavuzwe ko byanduye abantu 60 kubantu 100.000 kumunsiMutarama 1, 2021. Ibi bitekerezo ntabwo byerekana nezaahantu hose muri Amerika, ariko, byerekana rusangeibintu bisanzwe mu gihugu hose.Impinduka muri R tigihe gikomoka kubudahangarwa bwabonye no kwiyongeralence ya B.1.1.7, yagereranijwe, hamwe na B.1.1.7 R t yafashweguhora inshuro 1.5 R t yimpinduka zubu, zishingiyeibigereranyo byambere byaturutse mu Bwongereza (1,3).Ibikurikira, ingaruka zishobora gukingirwa zagereranijwedufate ko miliyoni imwe yinkingo yatanzwe kuri buriumunsi utangira ku ya 1 Mutarama 2021, kandi ubwo budahangarwa 95%byagezweho nyuma yiminsi 14 nyuma yo kubona dosiye 2.By'umwihariko,ubudahangarwa bwo kwandura hamwe nuburyo bugezweho cyangwaB.1.1.7 variant yafashwe, nubwo imikorere naigihe cyo gukingira indwara ntikiramenyekana,kuberako ibyo bitari iherezo ryibanze ryibigeragezo byamavuriroku nkingo za mbere.Muri ubu buryo, B.1.1.7 ubwiganze ni buke, nyamara kuberabirashoboka cyane kuruta ibigezweho, birerekanagukura byihuse mu ntangiriro za 2021, bihinduka byiganjeibimonyo muri Werurwe (Ishusho 1).Niba ihererekanyabubashaimpinduka ziriyongera (intangiriro R t = 1.1) cyangwa igabanuka buhoro(intangiriro R t = 0.9) muri Mutarama, B.1.1.7 itera impinduka zikomeyemu ihererekanyabubasha hamwe nicyiciro gishya cya exponentialgukura.Hamwe ninkingo irinda kwandura ,.inzira y'ibyorezo byambere ntabwo ihinduka kandi B.1.1.7 ikwirakwirabiracyagaragara (Ishusho 2).Ariko, nyuma ya B.1.1.7 ihindukavariant yiganje, ihererekanyabubasha ryaragabanutse cyane.Ingaruka zo gukingirwa mukugabanya kwanduza hafiijambo ryari rikomeye mubihe aho kwanduza kwaribimaze kugabanuka (intangiriro R t = 0.9) (Ishusho 2).Imbaraga zambereIrashobora kugabanya ikwirakwizwa rya B.1.1.7, nka rusange nakongera kubahiriza ingamba zo kugabanya ubuzima rusange,bizemerera igihe kinini kugirango urukingo rukomeze rugere hejuruubudahangarwa ku rwego rw'abaturage.

Ikiganiro

Kugeza ubu, nta tandukaniro rizwi mubisubizo byubuvuzibifitanye isano na SARS-CoV-2 yasobanuwe;arikoumuvuduko mwinshi wo kwanduza bizaganisha ku manza nyinshi, kwiyongeraumubare wabantu muri rusange bakeneye ubuvuzi, kwiyongeragukubita umutwaro kuri sisitemu yubuzima imaze gukomera,bikaviramo no gupfa.Gukomeza kugenzura genomickumenya B.1.1.7 imanza, kimwe no kugaragara kwizindiimpinduka zimpungenge muri Amerika, ni ngombwa kuriCOVID-19 igisubizo cyubuzima rusange.Mugihe ibisubizo bya SGTFirashobora gufasha kumenya ibibazo B.1.1.7 bishobora kwemezwamukurikirana, kumenya ibyihutirwa byambere bitagaragazaSGTF yishingikiriza gusa kubikurikirana bishingiye kumurongo.

 

 

 

Amazina atandukanye

Kumenyekanisha bwa mbere  

Imiterere ihindagurika

(poroteyine: mutation)

Oya y'imanza zemejwe zikurikiranye Oya

ibihugu hamwe

Urutonde

Aho biherereye Itariki Leta zunz'ubumwe Kwisi yose  
B.1.1.7 (20I / 501Y.V1) Ubwongereza Nzeri 2020 ORF1ab: T1001I, A1708D, I2230T,

del3675-3677 SGF

S: del69-70 HV, del144 Y, N501Y,

A570D, D614G, P681H, T761I,

S982A, D1118H

ORF8: Q27stop, R52I, Y73C

N: D3L, S235F

76 15.369 36
B.1.351 (20H / 501Y.V2) Afurika y'Epfo Ukwakira 2020 ORF1ab: K1655N

E: P71L

N: T205I

S: K417N, E484K, N501Y, D614G,

A701V

0 415 13

 

P.1 (20J / 501Y.V3 Burezili n'Ubuyapani Mutarama 2021 ORF1ab: F681L, I760T, S1188L,

K1795Q, del3675-3677 SGF, E5662D

S: L18F, T20N, P26S, D138Y, R190S,

K417T, E484K, N501Y, D614G,

H655Y, T1027I

ORF3a: C174G

ORF8: E92K

ORF9: Q77E

ORF14: V49L

N: P80R

0 35 2

 

Amagambo ahinnye: del = gusiba;E = ibahasha ya poroteyine;N = proteine ​​nucleocapsid;ORF = fungura ikadiri yo gusoma;S = intungamubiri.

Uburambe mubwongereza hamwe na B.1.1.7yatanzwe muri iyi raporo yerekana ingaruka zanduza cyanevariant irashobora kugira kumubare wimanza mubaturage.Uwitekakwiyongera kwanduza iyi variant bisaba nibindi byinshigushyira mu bikorwa ingamba zo gukingira hamwe na mitigaingamba zifatika (urugero, intera, guhisha, hamwe nisuku yintoki)kugenzura ikwirakwizwa rya SARS-CoV-2.Izi ngamba zizabagukora neza niba byashyizweho vuba vubakugabanya umuvuduko wambere wo gukwirakwiza B.1.1.7.Imbaraga kuritegura gahunda yubuzima kugirango irusheho kwiyongera mubibazo nibyemewe.Kwiyongera kwanduza nabyo bivuze ko biri hejurukuruta ibyateganijwe gukingirwa bigomba kugerwahokugera ku rwego rumwe rwo kurwanya indwara kugirango urinde abaturageugereranije nuburyo bworoshye bwo kwanduza.Ku bufatanye n’amasomo, inganda, leta, ifasi,amoko, nabafatanyabikorwa baho, CDC nizindi nzego za letabarimo guhuza no kuzamura igenzura rya genomic naimbaraga zo kuranga virusi muri Amerika.CDCihuza imbaraga zikurikirana muri Amerika binyuze muri SARS-CoV-2Urukurikirane rwubuzima rusange bwihutirwa,Epidemiologiya, no Gukurikirana (SPHERES)§§consortium,ikubiyemo ibigo bigera kuri 170 byitabira kandi bigatera inkunga gufungura amakuru-kugabana kugirango byorohereze ikoreshwa rya SARS-CoV-2amakuru akurikirana.Gukurikirana SARS-CoV-2 ihindagurika rya virusi, CDC nigushyira mubikorwa genomic igenzurwa ryinshi kugirango yumveepidemiologic, immunologic, na evolutioniyo shusho ya virusi ya virusi (phylodynamic);kuyobora icyorezoiperereza;no koroshya gutahura no kurangation yo gusubirwamo gushoboka, inkingo zatewe ninkingo, nakugaragara kwa virusi.Ugushyingo 2020, CDC yashinzwegahunda yigihugu ya SARS-CoV-2 Gahunda yo Kugenzura (NS3)kunoza guhagararirwa kwa SARS-CoV-2Urutonde.Porogaramu ikorana nabenegihugu 64 bo muri Amerikalaboratoire z'ubuzima kugirango zunganire sisitemu yo kugenzura genomic;NS3 yubaka kandi icyegeranyo cya SARS-CoV-2 ingero and ikurikiranye kugirango dushyigikire ubuzima rusange nubumenyiubushakashatsi bwo gusuzuma ingaruka zijyanye na mutation kuriisanzwe isabwa kurwanya imiti.CDC ifiteyagiranye amasezerano na laboratoire nini nini yubucuruzitori kugirango bikurikirane byihuse ibihumbi mirongo SARS-CoV-2-ingero nziza buri kwezi kandi yateye inkunga amasomo arindwiibigo byo kugenzura genomic mubufatanyehamwe n’ibigo nderabuzima rusange, bityo bikongerwaho cyane kurikuboneka kwamakuru ya genomic yo kugenzura mugihe gikwiyeAmerika.Usibye izi gahunda zigihugu,ibigo byinshi byubuzima rusange bya leta n’ibanze bikurikirana

FIGURE 1. Inzira zigereranijwe zerekana * * za SARS-CoV-2 zubu hamwe na B.1.1.7,dufate ko nta rukingo rw'abaturagekandi haba intangiriro R t = 1.1 (A) cyangwa R t = 0.9 (B) kubitandukanye-Amerika, Mutarama-Mata 2021

 

ishusho 1
ishusho 2
amagambo ahinnye
ishusho 1

SARS-CoV-2 kugirango wumve neza epidemiologiya yaho kandishyigikira igisubizo cyubuzima rusange bwicyorezo.Ibyavuye muri iyi raporo bikurikiza byibura limi eshatuIbitekerezo.Ubwa mbere, ubunini bwiyongera muri transmissibility muri Amerika ugereranije nibyagaragaye muriUbwongereza ntiburasobanuka neza.Icya kabiri, ubwinshi bwaB.1.1.7 muri Amerika nayo ntizwi muri iki gihe, arikogutahura ibitandukanye no kugereranya ubwiyongere bizatera imberehamwe nimbaraga zongerewe imbaraga zo kugenzura Amerika.Hanyuma, mitiga yahoingamba zifatika nazo zirahinduka cyane, biganisha ku guhinduka muriR.Ibisubizo byihariye byatanzwe hano bishingiye kuri simulations kandi byafashe ko nta gihinduka muri mituweli irenze 1 Mutarama.Kwiyongera kwanduza intambara ya B.1.1.7rants gushyira mubikorwa ingamba zubuzima rusange kurikugabanya kwanduza no kugabanya ingaruka zishobora guterwa na B.1.1.7,kugura igihe gikomeye cyo kongera inkingo.CDCkwerekana amakuru yerekana ko gukoresha isi yose no kongera compliance hamwe ningamba zo kugabanya no gukingira ni ngombwa kurigabanya umubare wimanza nshya nimpfu cyane muriamezi ari imbere.Byongeye, igeragezwa ryibikorwa byabantu badafiteibimenyetso bya COVID-19, ariko abafite ibyago byinshi kurikwandura na SARS-CoV-2, itanga andi mahirwe kurikugabanya gukomeza gukwirakwira.Hamwe na hamwe, kuzamura genomic ubushakashatsilance ihujwe no kongera kubahiriza ubuzima rusangeingamba zo kugabanya, harimo gukingirwa, intera y'umubiriing, gukoresha masike, isuku yintoki, no kwigunga na karantine,bizaba ngombwa kugabanya ikwirakwizwa rya SARS-CoV-2 nakurengera ubuzima rusange.

Gushimira

Abagize Urukurikirane rwubuzima rusange bwihutirwaIgisubizo, Epidemiologiya na Surveillance consortium;leta hamwe n’ibanzelaboratoire z'ubuzima rusange;Ishyirahamwe rya Laboratwari z'ubuzima rusange;Itsinda rya CDC COVID-19 Igisubizo;Ishami rya virusi z'ubuhumekero,Igabana ry'indwara ziterwa na virusi, CDC.Inama ishinzwe ibinyamakuru byubuvuzi ifishi yo kwerekana ubushoboziamakimbirane y'inyungu.Nta makimbirane ashobora kuba yatangajwe.

Reba

1. Ubuzima Rusange Ubwongereza.Iperereza ryibintu bishya SARS-CoV-2: impinduka zimpungenge 202012/01, ibisobanuro bya tekiniki 3. London, Ubwongereza: Ubuzima Rusange Ubwongereza;2020. https://assets.publishing.service.gov.uk/ guverinoma
2. Kemp SA, Harvey WT, Datir RP, n'abandi.Kugaragara kenshi no kwanduza SARS-CoV-2 gusiba spike ΔH69 / V70.bioRxiv [Icapiro ryashyizwe kumurongo 14 Mutarama 2021].https://www.biorxiv.org/content/10.1101/2020.12.14.422555v4
3. Volz E, Mishra S, Chand M, n'abandi.Ihererekanyabubasha rya SARS-CoV-2 umurongo B.1.1.7 mu Bwongereza: ubushishozi bwo guhuza amakuru ya epidemiologiya na genetique.medRxiv [Icapiro ryashyizwe kumurongo ku ya 4 Mutarama 2021].https://www.medrxiv.org/content/10.1101/2020.12.30.20249034v2
4. Honein MA, Christie A, Rose DA, n'abandi;Itsinda rya CDC COVID-19 Igisubizo.Incamake yubuyobozi bwingamba zubuzima rusange bwo gukemura ibibazo byinshi byanduza abaturage SARS-CoV-2 nimpfu ziterwa nayo, Ukuboza 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1860–7.PMID: 33301434 https://doi.org/10.15585/mmwr.mm6949e2
5. Volz E, Umusozi V, McCrone JT, n'abandi;COG-UK Consortium.Gusuzuma ingaruka za SARS-CoV-2 spike mutation D614G ku kwanduza no gutera indwara.Akagari 2021; 184: 64–75.e11.PMID: 33275900 https://doi.org/10.1016/j.cell.2020.11.020
6. Korber B, Fischer WM, Gnanakaran S, n'abandi;Sheffield COVID-19 Itsinda rya Genomika.Gukurikirana impinduka muri SARS-CoV-2: ibimenyetso byerekana ko D614G yongera ubwandu bwa virusi ya COVID-19.Akagari
2020; 182: 812-27.PMID: 32697968 https://doi.org/10.1016/j.cell.2020.06.043
7. McCarthy KR, Rennick LJ, Namnulli S, n'abandi.Gusiba bisanzwe muri SARS-CoV-2 spike glycoprotein itwara antibody ihunga.bioRxiv [Icapiro ryashyizwe kumurongo 19 Ugushyingo 2020].https://www.biorxiv.org/content/
10.1101 / 2020.11.19.389916v18.Washington NL, White S, Schiabor KM, Cirulli ET, Bolze A, Lu JT.S uburyo bwo guta gene mu bizamini bya SARS-CoV-2 byerekana ko ikwirakwizwa rya mutation ya H69del / V70del muri Amerika.medRxiv [Icapiro ryashyizwe kumurongo 30 Ukuboza 2020].https://www.medrxiv.org/content/10.1101/2020.12.24.20248814v1
9. Weisblum Y, Schmidt F, Zhang F, n'abandi.Guhunga kutabuza antibodi na SARS-CoV-2 spike protein variants.Ubuzima bwa 2020; 9: e61312.PMID: 33112236 https://doi.org/10.7554/Ubuzima.61312
10. Greaney AJ, Loes AN, Crawford KHD, nabandi.Gushushanya byimazeyo ihinduka ryimiterere kuri SARS-CoV-2 reseptor-binding domaine igira ingaruka kumenyekanisha na antibodiyumu ya serumu yumuntu.bioRxiv [Icapiro ryashyizwe kumurongo 4 Mutarama 2021].https://www.biorxiv.org/content/10.1101/2020.12.31.425021v1


Igihe cyo kohereza: Gashyantare-11-2021